Oncotelic Therapeutics, Inc. — Form D

Oncotelic Therapeutics, Inc. of AGOURA HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-22. The offering totals $712K, of which $712K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
SHAH AMITRelated PersonAGOURA HILLS, CA
Seymour FeinRelated PersonAGOURA HILLS, CA
Steven KingRelated PersonAGOURA HILLS, CA
Anthony MaidaRelated PersonRaleigh, NC
Saran SaundRelated PersonAGOURA HILLS, CA
VUONG TRIEURelated PersonAGOURA HILLS, CA
VUONG TRIEUDirectorAGOURA HILLS, CA
VUONG TRIEUExecutive OfficerAGOURA HILLS, CA
James B MurphyExecutive OfficerWORCESTER, MA
Amit ShahExecutive OfficerSAN MATEO, CA
Saran SaundExecutive OfficerAGOURA HILLS, CA
Seymour FeinExecutive OfficerAGOURA HILLS, CA
Anthony MaidaExecutive OfficerRaleigh, NC
William SchwietermanDirectorHouston, TX
BOBBY W SANDAGE, JR.DirectorST. LOUIS, MO
Chuho ParkExecutive OfficerAgoura Hills, CA
Fatih UckunExecutive OfficerAgoura Hills, CA
Chulho ParkExecutive OfficerAgoura Hills, CA
Matthew LoarExecutive OfficerSouth San Francisco, CA
Roy H FicklingDirectorAtlanta, GA
William D SchwietermanDirectorSouth San Francisco, CA
William D SchwietermanExecutive OfficerSouth San Francisco, CA
Simon C PedderDirectorSouth San Francisco, CA
David J ChaplinDirectorSouth San Francisco, CA
David J ChaplinExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2025-12-11D$12.5M$275K
2023-07-13D$5.0M
2020-08-04D$5.0M$2.0M
2019-05-07D$1.2M$600K
2019-05-07D$27.0M$27.0M
2018-04-25D$12.0M$2.9M
2010-03-26D$7.5M$7.5M

More